With the intention to understand and ensure successful adoption of tuberculosis (TB) diagnostic tools, the “Critical Pathway for New TB Diagnostics” project was initiated. Nine countries, where TB is a cause for concern, came together to map a streamlined pathway outlining the key steps from approval to the nationwide rollout of new TB tests. Each country designed a nationally relevant pathway for itself.

CHRF, in collaboration with McGill University, led the pathway development for Bangladesh, working closely with national stakeholders to reflect local systems and barriers.

This multi-country effort, funded by the Gates Foundation, aims to create a durable, practical resource that guides manufacturers and global partners in integrating TB tools efficiently into health systems. At its core, the work is about bridging the gap between promising TB diagnostic tools and communities in need.